Afya Stock Valuation

AFYA
 Stock
  

USD 15.04  0.21  1.38%   

Do you wonder what the value of Afya is? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Afya, is its stock price multiplied by the total number of shares outstanding, calculating Afya's enterprise value requires a different approach. It uses Afya's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Afya shows a prevailing Real Value of $17.65 per share. The current price of the firm is $15.04. At this time, the firm appears to be undervalued. Our model approximates the value of Afya from analyzing the firm fundamentals such as Current Valuation of 1.67 B, return on equity of 0.12 %, and Profit Margin of 0.16 % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor taking in undervalued instruments and trading overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
  
Afya Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Afya's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

Afya Most Recent Valuation Data

Beta
0.8825
Fiscal Year End
December
Property Plant And Equipment Net
1.1 B
Enterprise Value
1.7 B
Current Deferred Revenue
114.6 M
Net Debt
1.4 B
Undervalued
Today 15.04
Please note that Afya's price fluctuation is not too volatile at this time. Calculation of the real value of Afya is based on 3 months time horizon. Increasing Afya's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Afya is useful when determining the fair value of the Afya stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Afya. Since Afya is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Afya Stock. However, Afya's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
17.65
Real Value
20.47
Upside
Estimating the potential upside or downside of Afya helps investors to forecast how Afya stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Afya more accurately as focusing exclusively on Afya's fundamentals will not take into account other important factors:
Earnings
Estimates (2)
LowProjected EPSHigh
0.450.570.69
Details
Hype
Prediction
LowEstimated ValueHigh
12.4515.2718.09
Details
Naive
Forecast
LowNext ValueHigh
12.8115.6318.45
Details
4 Analysts
Consensus
LowTarget PriceHigh
20.5025.3331.00
Details

Afya Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Afya's current stock value. Our valuation model uses many indicators to compare Afya value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Afya competition to find correlations between indicators driving Afya's intrinsic value. More Info.
Afya is number one stock in beta category among related companies. It is number one stock in net asset category among related companies making up about  7,305,842,493  of Net Asset per Beta. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Afya by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Afya's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Afya's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Afya's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Afya and how it compares across the competition.

About Afya Valuation

The stock valuation mechanism determines the current worth of Afya on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Afya. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Afya based exclusively on its fundamental and basic technical indicators. By analyzing Afya's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Afya's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Afya. We calculate exposure to Afya's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Afya's related companies.
Fiscal Year End
December
Industry
Education & Training Services
Concentration
Education Services
Service Category
Diversified Consumer Services
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company was founded in 1999 and is headquartered in Nova Lima, Brazil. Afya is traded on NASDAQ Exchange in the United States.

Afya Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Afya does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quarterly Earnings Growth Y O Y0.5
Please continue to Trending Equities. You can also try Fund Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for analysis

When running Afya price analysis, check to measure Afya's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Afya is operating at the current time. Most of Afya's value examination focuses on studying past and present price action to predict the probability of Afya's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Afya's price. Additionally, you may evaluate how the addition of Afya to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Is Afya's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Afya. If investors know Afya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Afya listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.5
Market Capitalization
1.4 B
Quarterly Revenue Growth YOY
0.278
Return On Assets
0.0608
Return On Equity
0.119
The market value of Afya is measured differently than its book value, which is the value of Afya that is recorded on the company's balance sheet. Investors also form their own opinion of Afya's value that differs from its market value or its book value, called intrinsic value, which is Afya's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Afya's market value can be influenced by many factors that don't directly affect Afya's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Afya's value and its price as these two are different measures arrived at by different means. Investors typically determine Afya value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Afya's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.